FDA vaccine advisers recommend emergency use for booster doses of the modern Covid-1 vaccine

The FDA’s Vaccine and Related Organic Products Advisory Committee has agreed that using a booster dose will be safe and effective for some people beyond six months from their initial series.

Moderena sought approval for emergency use for half the dose of her vaccine so that it could be used as a booster for some people.

All 19 members of the committee supported approving the 50-microgram booster dose-half the size of the 100-microgram dose used in the initial series of two-dose vaccines কম at least six months after the second dose and only certain groups: people 65 years of age or older; People aged 18 to 64 who are at risk of the deadly covid-1 of; And people between the ages of 18 and 64 who are exposed to the coronavirus have their settings or jobs at risk for complications of Covid-1 complications or serious illness.

Modern EU requests reflect groups approved to receive a booster dose of Pfizer’s mRNA vaccine. The third dose of the Moderena and Pfizer Covid-1 vaccines has already been approved for some immunocompromised people.

Committee members said they were not entirely sure if the data showed that a booster was needed or that it increased security.

“The data isn’t perfect but these are tremendous times and we have to work with incomplete data,” said Drs. Eric Rubin says health.

“We can’t afford healthcare workers, even if they’re not sick, to be positive and infected and stay home from work because there is a shortage of healthcare workers in some parts of the country and there are burns everywhere,” he said. Stanley Pearlman, Professor of Pediatrics at the University of San Diego, California.

A meeting of the Vaccine and Related Organic Products Advisory Committee will take place on Friday, when members are expected to vote on the booster for the Johnson & Johnson vaccine, and hear a presentation on the mix and match vaccine.

The FDA’s committee of independent advisers usually consults and recommends the agency around vaccine approvals and approvals, and the agency then makes the final decision on whether to fix the vaccine.

If the FDA approves the emergency use of modern booster, vaccine advisers from the U.S. Centers for Disease Control and Prevention will discuss which group to recommend them to. Typically, shots can be managed if the CDC director signs the recommendation.

The CDC’s Advisory Committee on Immunization Practice is already scheduled for October 21 to discuss the booster.

CNN’s Jacqueline Howard contributed to this report.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button